NCT05032092View on ClinicalTrials.gov

Evaluation of Efficacy of Comprehensive Genomic Tumour Profiling (CGP) from Liquid And/or Tissue Biopsy in Patients with Locally Advanced And/or Metastatic Solid Cancer

NARecruitingINTERVENTIONAL
Enrollment

235

Participants

Timeline

Start Date

November 24, 2021

Primary Completion Date

July 31, 2025

Study Completion Date

June 30, 2026

Conditions
Locally Advanced CarcinomaMetastatic Cancer
Interventions
DIAGNOSTIC_TEST

Next Generation Sequencing

Molecular analysis of liquid biopsy.

DIAGNOSTIC_TEST

Next Generation Sequencing

Molecular analysis of tissue biopsy.

GENETIC

Biomarker Monitoring

Biomarker Monitoring of study patients receiving matched therapy.

Trial Locations (5)

4010

RECRUITING

Ordensklinikum Linz, Linz

5020

RECRUITING

University Hospital Salzburg, Department of Internal Medicine III, Salzburg

6020

ACTIVE_NOT_RECRUITING

Medical University of Innsbruck, Department of Hematology and Oncology, Innsbruck

6807

RECRUITING

Landeskrankenhaus Feldkirch, Department of Internal Medicine II, Feldkirch

8036

RECRUITING

Medical University of Graz, Graz

All Listed Sponsors
lead

Medical University of Graz

OTHER